
GoHealth, Inc. (GOCO) Stock Forecast & Price Target
GoHealth, Inc. (GOCO) Analyst Ratings
Bulls say
GoHealth Inc. has recently demonstrated stabilized membership persistency and lifetime value (LTV), indicating a more rationalized approach to marketing spend within the industry. The company anticipates flat year-over-year revenue while benefiting from expected growth in submission volume aligned with the broader Medicare market, suggesting healthy operating conditions. Furthermore, an upgraded adjusted EBITDA estimate for 2025 to $100.9 million reflects confidence in the performance of the Encompass platform, which enhances revenue and cash flow visibility without the implications of ASC-606 accounting.
Bears say
GoHealth is experiencing diminished topline visibility, evidenced by a fourth-quarter revenue miss, leading to a downward revision of its 2024 revenue estimate from $765.6 million to $741.7 million. The company faces significant headwinds related to persistency that are expected to result in negative tail-revenue and lower cash received from commissions, with adjusted EBITDA forecasts reflecting declines of approximately 15% to 20% from base case estimates. Additionally, various risks—including growing competition, dependence on a limited number of carrier partners, and increasing customer churn—further contribute to a negative outlook for the company's financial performance.
This aggregate rating is based on analysts' research of GoHealth, Inc. and is not a guaranteed prediction by Public.com or investment advice.
GoHealth, Inc. (GOCO) Analyst Forecast & Price Prediction
Start investing in GoHealth, Inc. (GOCO)
Order type
Buy in
Order amount
Est. shares
0 shares